<?xml version="1.0" encoding="ISO-8859-1"?>
<entity-relation-data lastUpdate="2023-03-27 16:21:18" record="9794" source="Espacenet">
	<entities>
		<entity ref="Patent9794" type="Patent">
			<semanticIdentifier>brcris::e87b5dc2efed7a82fab59a8044dd3e0d</semanticIdentifier>
			<semanticIdentifier>docdb::BR9903382A</semanticIdentifier>
			<semanticIdentifier>epodoc::BR9903382</semanticIdentifier>
			<semanticIdentifier>docdb::BR9903382A</semanticIdentifier>
			<semanticIdentifier>epodoc::BR19999903382</semanticIdentifier>
			<semanticIdentifier>original::9903382-8</semanticIdentifier>
			<field name="urlEspacenet" value="https://worldwide.espacenet.com/patent/search?q=9903382"/>
			<field name="identifier.lattes" value="9323158689549288"/>
			<field name="identifier.espacenet" value="9903382"/>
			<field name="kindCode" value="A"/>
			<field name="title.espacenet" value="Copolìmeros de ácido acrìlico ou metacrìlico/l-dopa, de ácido acrìlico ou metacrìlico/l-&lt;244&gt; metildopa ou de ácido acrìlico ou metacrìlico/l-carbidopa, processo de sua obtenção e composições medicamentosas contendo os mesmos"/>
			<field name="title.lattes" value="Kontrollierte Freisetzung aus Copolymeren von Acryl- oder Methacrylsäure/L-a-Methyldopa, Acryl- oder Methacrylsäure/Carbidopa und deren Kombinationen"/>
			<field name="depositDate" value="1999-08-04"/>
			<field name="publicationDate" value="2001-03-20"/>
			<field name="countryCode" value="BR"/>
			<field name="inventor" value="CRISTINA TRISTAO DE ANDRADE"/>
			<field name="inventor" value="DAVID TABAK"/>
			<field name="inventor" value="FABIO MOYSES LINS DANTAS"/>
			<field name="applicant" value="FUNDACAO OSWALDO CRUZ - FIOCRUZ"/>
			<field name="classification.ipc">
				<field name="sequence" value="1"/>
				<field name="text" value="A61K31/198AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="31"/>
				<field name="subgroup" value="198AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="2"/>
				<field name="text" value="A61K47/48AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="47"/>
				<field name="subgroup" value="48AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="3"/>
				<field name="text" value="A61P9/02AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="9"/>
				<field name="subgroup" value="02AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="4"/>
				<field name="text" value="A61P25/16AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="25"/>
				<field name="subgroup" value="16AI"/>
			</field>
			<field name="abstract.espacenet" value="Patente de Invenção: &quot;COPOLìMEROS DE áCIDO ACRìLICO OU METACRìLICO/L-DOPA, DE áCIDO ACRìLICO OU METACRìLICO/L-&lt;244&gt;-METILDOPA OU DE áCIDO ACRìLICO OU METACRìLICO/L-CARBIDOPA, PROCESSO DE SUA OBTENçãO E COMPOSIçõES MEDICAMENTOSAS CONTENDO OS MESMOS&quot; A presente invenção tem relação com sistemas de distribuição de drogas do tipo vetorizado, propiciando a liberação controlada de L-dopa, carbidopa, L-&lt;244&gt;-metildopa e/ou suas combinações, com o objetivo de eliminar ou pelo menos reduzir os efeitos colaterais deletérios das mesmas. Os copolímeros biologicamente ativos tendo características do tipo sítio dirigido para tecido mucoso do sistema digestivo compreendem L-dopa, carbidopa ou L-&lt;244&gt;-metildopa quimicamente combinados com poli (ácido acrílico) ou poli (ácido metacrílico) biologicamente aceitável. Os copolímeros são obtidos através de um processo compreendendo as etapas de: (a) reação da L-dopa, carbidopa ou L-&lt;244&gt;-metildopa com um agente de cloração; (b) reação do produto da etapa (a) com poli (ácido acrílico) ou poli (ácido metacrílico) na presença de um catalisador apropriado; (c) lavagem do copolímero obtido na etapa (b) com um solvente orgânico apropriado e processamento de sua secagem até o alcance de peso constante. Os medicamentos anti-hipertensivos de liberação controlada da presente invenção compreendem pelo menos um copolímero biologicamente ativo selecionado do grupo consistindo de poli (ácido acrílico/L-&lt;244&gt;-metildopa), poli (ácido acrílico/carbidopa), poli (ácido metacrílico/carbidopa), ou suas combinações, e um veículo farmaceuticamente aceitável. Os medicamentos de liberação controlada da presente invenção também compreendem pelo menos um copolímero biologicamente ativo selecionado do grupo consistindo de poli (ácido acrílico/L-dopa), poli (ácido metacrílico/L-dopa), poli (ácido acrílico/carbidopa), poli (ácido metacrílico/carbidopa) ou suas combinações e um veículo farmaceuticamente aceitável os quais podem ser usados no tratamento da síndrome de Parkinson."/>
			<field name="originatesFrom" value="4073069"/>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="9903382"/>
				<field name="kind" value="A"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR9903382"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="9903382"/>
				<field name="kind" value="A"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR19999903382"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="original"/>
				<field name="country" value=""/>
				<field name="number" value="9903382-8"/>
				<field name="kind" value=""/>
			</field>
			<field name="urlEspacenet" value="https://worldwide.espacenet.com/patent/search?q=AU6142600"/>
			<field name="urlEspacenet" value="https://worldwide.espacenet.com/patent/search?q=CA2346291"/>
			<field name="urlEspacenet" value="https://worldwide.espacenet.com/patent/search?q=DE10082749T"/>
			<field name="urlEspacenet" value="https://worldwide.espacenet.com/patent/search?q=EP1117370"/>
			<field name="urlEspacenet" value="https://worldwide.espacenet.com/patent/search?q=GB0111066D0"/>
			<field name="urlEspacenet" value="https://worldwide.espacenet.com/patent/search?q=GB2384426"/>
			<field name="urlEspacenet" value="https://worldwide.espacenet.com/patent/search?q=WO0110378"/>
			<field name="urlEspacenet" value="https://worldwide.espacenet.com/patent/search?q=WO0110378"/>
		</entity>
		<entity ref="Person6717" type="Person">
			<semanticIdentifier>lattes::9323158689549288</semanticIdentifier>
			<field name="identifier.lattes" value="9323158689549288"/>
			<field name="name" value="Cristina Tristão de Andrade"/>
		</entity>
		<entity ref="OrgUnit5294" type="OrgUnit">
			<semanticIdentifier>brcris::7ab85eeef0104ad2df1f2e6200971acd</semanticIdentifier>
			<field name="name" value="FUNDACAO OSWALDO CRUZ - FIOCRUZ"/>
		</entity>
		<entity ref="Patent9795" type="Patent">
			<semanticIdentifier>epodoc::AU6142600</semanticIdentifier>
			<field name="countryCode" value="AU"/>
			<field name="originatesFrom" value="4073069"/>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="AU"/>
				<field name="number" value="AU6142600"/>
				<field name="kind" value=""/>
			</field>
		</entity>
		<entity ref="Patent9796" type="Patent">
			<semanticIdentifier>epodoc::CA2346291</semanticIdentifier>
			<field name="countryCode" value="CA"/>
			<field name="originatesFrom" value="4073069"/>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="CA"/>
				<field name="number" value="CA2346291"/>
				<field name="kind" value=""/>
			</field>
		</entity>
		<entity ref="Patent9797" type="Patent">
			<semanticIdentifier>epodoc::DE10082749T</semanticIdentifier>
			<field name="countryCode" value="DE"/>
			<field name="originatesFrom" value="4073069"/>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="DE"/>
				<field name="number" value="DE10082749T"/>
				<field name="kind" value=""/>
			</field>
		</entity>
		<entity ref="Patent9798" type="Patent">
			<semanticIdentifier>epodoc::EP1117370</semanticIdentifier>
			<field name="countryCode" value="EP"/>
			<field name="originatesFrom" value="4073069"/>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="EP"/>
				<field name="number" value="EP1117370"/>
				<field name="kind" value=""/>
			</field>
		</entity>
		<entity ref="Patent9799" type="Patent">
			<semanticIdentifier>epodoc::GB0111066D0</semanticIdentifier>
			<field name="countryCode" value="GB"/>
			<field name="originatesFrom" value="4073069"/>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="GB"/>
				<field name="number" value="GB0111066D0"/>
				<field name="kind" value=""/>
			</field>
		</entity>
		<entity ref="Patent9800" type="Patent">
			<semanticIdentifier>epodoc::GB2384426</semanticIdentifier>
			<field name="countryCode" value="GB"/>
			<field name="originatesFrom" value="4073069"/>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="GB"/>
				<field name="number" value="GB2384426"/>
				<field name="kind" value=""/>
			</field>
		</entity>
		<entity ref="Patent9801" type="Patent">
			<semanticIdentifier>epodoc::WO0110378</semanticIdentifier>
			<field name="countryCode" value="WO"/>
			<field name="originatesFrom" value="4073069"/>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="WO"/>
				<field name="number" value="WO0110378"/>
				<field name="kind" value=""/>
			</field>
		</entity>
		<entity ref="Patent9802" type="Patent">
			<semanticIdentifier>epodoc::WO0110378</semanticIdentifier>
			<field name="countryCode" value="WO"/>
			<field name="originatesFrom" value="4073069"/>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="WO"/>
				<field name="number" value="WO0110378"/>
				<field name="kind" value=""/>
			</field>
		</entity>
	</entities>
	<relations>
		<relation fromEntityRef="Patent9794" toEntityRef="Person6717" type="Inventor"/>
		<relation fromEntityRef="Patent9794" toEntityRef="OrgUnit5294" type="Applicant"/>
	</relations>
</entity-relation-data>
